Early James 4/A
4/A · Interpace Diagnostics Group, Inc. · Filed Mar 8, 2019
Insider Transaction Report
Form 4/AAmended
Early James
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2018-12-05+12,000→ 12,000 totalExercise: $1.08Exp: 2028-12-05→ Common Stock (12,000 underlying) - Award
Common Stock
2018-12-05+3,000→ 17,000 total
Footnotes (4)
- [F1]On December 6, 2018, the award of restricted stock units was inadvertently omitted from the reporting person's Form 4 filing. The restricted stock units vest annually, in equal installments, over a three-year period, commencing on December 5, 2019.
- [F2]Each restricted stock unit represents the contingent right to receive one share of common stock of the Issuer.
- [F3]On December 6, 2018, the award of stock options was inadvertently overstated on the reporting person's Form 4 filing as 15,000 stock options. 12,000 stock options were awarded.
- [F4]The stock options vest and become exercisable over a three-year period, in equal installments, commencing on December 5, 2019, subject to the reporting person's continued service with the Issuer.